Surgery Partners, Inc.
SGRY
$12.36
-$0.29-2.29%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -77.90M | -171.40M | -180.40M | -193.40M | -168.10M |
| Total Depreciation and Amortization | 176.00M | 150.00M | 160.70M | 155.20M | 152.60M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 286.60M | 427.20M | 416.90M | 441.70M | 434.50M |
| Change in Net Operating Assets | -110.40M | -123.50M | -133.30M | -138.10M | -118.90M |
| Cash from Operations | 274.30M | 282.30M | 263.90M | 265.40M | 300.10M |
| Capital Expenditure | -78.70M | -88.20M | -88.60M | -92.10M | -90.40M |
| Sale of Property, Plant, and Equipment | 46.50M | 44.00M | 44.00M | 5.90M | 2.60M |
| Cash Acquisitions | -162.10M | -140.20M | -162.20M | -368.20M | -378.80M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -52.30M | -47.80M | -28.80M | -27.40M | -21.90M |
| Cash from Investing | -246.60M | -232.20M | -235.60M | -481.80M | -488.50M |
| Total Debt Issued | 1.20B | 776.00M | 816.50M | 1.75B | 1.73B |
| Total Debt Repaid | -1.04B | -630.90M | -604.90M | -1.28B | -1.28B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -220.10M | -213.60M | -203.30M | -211.90M | -188.40M |
| Cash from Financing | -57.30M | -68.50M | 8.30M | 260.50M | 262.00M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -29.60M | -18.40M | 36.60M | 44.10M | 73.60M |